REFERENCES
- Dorward S, Sreedharan A, Leontiadis GI, Howden CW, Moayyedi P, Forman D. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2006; CD005415.
- Galmiche JP, Letessier E, Scarpignato C. Treatment of gastro-oesophageal reflux disease in adults. Br Med J. 1998; 316:1720–3.
- Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006;367:2086–100.
- Leontiadis GI, McIntyre L, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. 2004; CD002094.
- Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, et al. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess. 2007; 11:iii–iv, 1–164.
- Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: A clinical overview. Dig Liver Dis. 2008;40:619–26.
- Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24:121–32.
- Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. Br Med J. 2008;336:2–3.
- Mössner J. Gastrointestinal drugs and laxatives [Magen- Darm-Mittel und Laxantien]. In: Schwabe U, Pfaffrath D, eds. Drug prescription report 2011 [Arzneiverordnungsreport 2011]. Berlin, Heidelberg, New York: Springer; 2011. pp. 681–709.
- Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.Br Med J. 1998;317:452–6.
- Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000;25:333–40.
- Walker NM, McDonald J. An evaluation of the use of proton pump inhibitors. Pharm World Sci. 2001;23:116–7.
- Gardner TB, Robertson DJ. Stress ulcer prophylaxis in non- critically ill patients: Less may be more. Am J Gastroenterol. 2006;101:2206–8.
- Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006;101:2200–5.
- Molloy D, Molloy A, O’Loughlin C, Falconer M, Hennessy M. Inappropriate use of proton pump inhibitors. Ir J Med Sci. 2010;179:73–5.
- van Vliet EP, Otten HJ, Rudolphus A, Knoester PD, Hoogsteden HC, Kuipers EJ, et al. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. Eur J Gastroenterol Hepatol. 2008;20:608–12.
- Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, et al. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: A 1-month survey. Aliment Pharmacol Ther. 2003;17:1503–6.
- Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care—a large-scale follow-up study. Eur J Clin Pharmacol. 2007;63: 783–90.
- Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. J Am Med Assoc. 2004;292: 1955–60.
- Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. J Am Med Assoc. 2006;296:2947–53.
- Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile- associated disease defined by prescription for oral vancomycin therapy. Can Med Assoc J. 2006;175:745–8.
- Roth-Isigkeit A, Harder S. Medication in discharge letters [Die Entlassungsmedikation im Arztbrief]. Med Klin. 2005;100: 87–93.
- Ahrens D, Chenot JF, Behrens G, Grimmsmann T, Kochen MM. Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur J Clin Pharmacol. 2010;66: 1265–71.
- Ahrens D, Behrens G, Himmel W, Kochen M, Chenot JF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract. 2012;66:767–73.
- Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Brymann A, Burgess R, editors. Analysing qualitative data. London: Routledge; 1994. pp. 173–94.
- Grime J, Pollock K, Blenkinsopp A. Proton pump inhibitors: perspectives of patients and their GPs. Br J Gen Pract. 2001; 51:703–11.
- Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): Patient self-regulation of treatment may be an under-exploited resource. Soc Sci Med. 2000; 51:1827–39.
- Dubois RW, Melmed GY, Henning JM, Laine L. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther. 2004;19:197–208.
- Jaye C, Tilyard M. A qualitative comparative investigation of variation in general practitioners’ prescribing patterns. Br J Gen Pract. 2002;52:381–6.
- Lewis PJ, Tully MP. The discomfort of an evidence-based prescribing decision. J Eval Clin Pract. 2009;15:1152–8.
- Lewis PJ, Tully MP. Uncomfortable prescribing decisions in hospitals: The impact of teamwork. J R Soc Med. 2009;102:481–8.
- Yachimski PS, Farrell EA, Hunt DP, Reid AE. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice. Arch Intern Med. 2010;170:779–83.